Thematic Meeting on Immuno-Oncology
Come discover the implemented strategies to transform a target into a therapeutic innovation !
Eurobiomed invites you to its first Thematic Meeting of the year dedicated to the latest innovations in immuno-oncology
Thanks to the participation of key actors of immuno-oncology, this event will be the occasion to browse the development of all of the new immunotherapies !
Beyond the hopes aroused by the discovery and the development of new targets, this event will also be the occasion to highlight the collaborative innovations enabling transformation of drug candidates into therapeutic success.
January 23rd 2018,
Timone AP-HM Hospital - Amphitheatre HA2
(264 rue Saint Pierre 13885 Marseille - plan d'accès)
|10h ||Welcome of the participants|
Opening of the Thematic Meeting and Update on Marseille Immunopole
Emilie ROYERE, General Manager - Eurobiomed
Daniel OLIVE, Head of the team "Immunity and Cancer | Manager of the immune-mentoring CRCM/IPC plateform | Co-founder of ImCheck Therapeutics
Pierre MARTINEAU / Bernaud PAU , Co-founders
François ROMAGNÉ, Scientific Director
Dominique COSTANTINI, CEO and Director
Mondher MAHJOUBI - Chairman of the Executive Board and CEO
Thierry WURCH, Director - External Research and Innovation in Immuno-Oncology
Jean-François PROST, VP - R&D & Strategy
Amélie CORNILLON, Technical & Scientific Manager
Fabienne HERMITTE, VP Medical Affairs
AP-HM / RHU PIONeeR
Fabrice BARLESI, Head of the Service Multidisciplinary Oncology and therapeutic innovations
For more information : Nicolas Sainte-Foie : firstname.lastname@example.org - +33 (0)6 61 78 12 53